Bioidentical Hormones: What the Evidence Actually Says

Bioidentical hormones have become one of the most debated topics in hormonal medicine. Depending on who you ask, they're either the natural, safer alternative to synthetic hormones — or they're an unregulated Wild West of compounded preparations with no evidence advantage. The truth, as usual, is more nuanced than either side suggests.

If you're considering hormone therapy and trying to make sense of the bioidentical versus synthetic conversation, this article gives you the research — not the marketing.

What "Bioidentical" Actually Means

Bioidentical hormones are molecularly identical to the hormones your body produces. They have the exact same chemical structure as endogenous human hormones.

Bioidentical hormones include:

• Estradiol (17-beta estradiol) — The primary estrogen your ovaries produce
• Progesterone (micronized) — Identical to the progesterone produced by the corpus luteum
• Testosterone — Same molecule your body produces
• DHEA — Identical to adrenally-produced DHEA

What bioidentical does NOT mean:

• "Natural" — Bioidentical hormones are synthesized in a lab, typically from plant precursors (soy or yam). The starting material is natural, but the final product is manufactured. "Natural" is a marketing term, not a scientific one.
• "Unregulated" — FDA-approved bioidentical hormones exist and are well-regulated
• "Compounded" — Bioidentical hormones can be either FDA-approved or custom-compounded. These are different categories with different implications.

FDA-Approved Bioidentical Options

This is important and often overlooked: many FDA-approved hormone products ARE bioidentical. The conversation isn't "bioidentical vs. FDA-approved" — it's "compounded vs. FDA-approved," and both categories can contain bioidentical hormones.

FDA-approved bioidentical estradiol:

• Transdermal patches: Vivelle-Dot, Climara, Menostar
• Topical gels: EstroGel, Divigel, Elestrin
• Topical spray: Evamist
• Vaginal ring: Femring, Estring
• Vaginal cream: Estrace cream
• Vaginal tablet: Vagifem, Yuvafem
• Oral: Estrace (oral estradiol)

FDA-approved bioidentical progesterone:

• Prometrium (oral micronized progesterone)
• Endometrin (vaginal progesterone)
• Crinone (vaginal progesterone gel)

FDA-approved bioidentical testosterone (for men):

• Multiple injectable, topical, and oral formulations

These products have undergone rigorous testing for safety, efficacy, potency, purity, and bioavailability. They have consistent manufacturing standards, lot-to-lot reliability, and post-market surveillance.

Compounded Bioidentical Hormones

Compounded bioidentical hormones are custom-prepared by compounding pharmacies, typically based on a prescriber's specifications. They can include combinations of hormones in specific doses, delivered through various routes (creams, capsules, troches, pellets, drops).

When compounding is genuinely useful:

• Doses not available in commercial products
• Hormone combinations not available commercially (e.g., Biest — a combination of estradiol and estriol)
• Alternative delivery methods (e.g., sublingual, transdermal cream in specific concentrations)
• Allergy to inactive ingredients in commercial products
• Testosterone for women (no FDA-approved testosterone product exists for women)

The concerns with compounding:

Lack of FDA oversight. Compounding pharmacies are regulated by state pharmacy boards, not the FDA. Quality standards vary significantly between pharmacies. The FDA does not verify the potency, purity, sterility, or bioavailability of compounded products.

Inconsistent potency. Studies evaluating compounded hormone preparations have found significant variability in actual hormone content compared to labeled content. A preparation labeled as 1 mg estradiol might contain 0.7 mg or 1.4 mg. This inconsistency can lead to unpredictable clinical effects and difficulty optimizing dosing.

Lack of clinical trial data. Compounded formulations generally have not undergone the randomized controlled trials that FDA-approved products have. Their safety and efficacy are inferred from the properties of the individual hormones rather than demonstrated for the specific compounded product.

Estriol: the most debated compound. Estriol (E3) is a weak estrogen commonly included in compounded "Biest" (80% estriol / 20% estradiol) preparations. Proponents argue it's safer and more "physiological." However:

• There's no FDA-approved estriol product
• Limited clinical trial data on estriol for menopausal symptoms
• The claim that estriol is "safer" because it's weaker doesn't have strong evidence — if you need more of a weaker hormone to achieve the same effect, the safety advantage is theoretical
• Some studies suggest estriol may have beneficial effects, but the evidence base is thin compared to estradiol

Pellets. Hormone pellets (implanted subcutaneously) have gained popularity. Concerns include:

• Supraphysiological levels — pellets can produce hormone peaks well above normal ranges
• Difficulty adjusting — once implanted, you can't reduce the dose if side effects occur
• Inconsistent absorption
• No FDA-approved pellet product for women

Bioidentical vs. Synthetic: What Does the Evidence Say?

Progesterone vs. Synthetic Progestins

This is where the evidence most clearly supports a bioidentical advantage:

Micronized progesterone (Prometrium) vs. medroxyprogesterone acetate (Provera):

• The WHI study (which caused the HRT scare in 2002) used Provera, not bioidentical progesterone. The estrogen-plus-Provera arm showed increased breast cancer risk. The estrogen-only arm did not.
• French E3N study (80,000+ women): Estrogen combined with micronized progesterone showed no increased breast cancer risk over 8 years of follow-up. Estrogen combined with synthetic progestins did show increased risk.
• Micronized progesterone has more favorable effects on lipids (doesn't negate estrogen's HDL-raising effect, while some synthetic progestins do)
• Micronized progesterone has anxiolytic and sleep-promoting effects through allopregnanolone. Synthetic progestins don't produce this metabolite.
• Micronized progesterone appears to have a better cardiovascular safety profile

Clinical consensus: Most menopause specialists now prefer micronized progesterone over synthetic progestins when progesterone is needed. This is one of the clearest evidence-based advantages of a bioidentical hormone.

Estradiol vs. Conjugated Equine Estrogens (Premarin)

Premarin is derived from pregnant mare urine and contains a mix of estrogens, many of which are equine (horse) hormones not identical to human estrogens.

Transdermal estradiol vs. oral Premarin:

• Transdermal estradiol does not increase clotting risk. Oral Premarin does (modestly). This is primarily a route-of-delivery difference rather than a bioidentical vs. non-bioidentical difference, but transdermal delivery is only available with bioidentical estradiol.
• Both effectively treat menopausal symptoms
• Both provide bone protection
• Transdermal estradiol has more favorable effects on triglycerides and C-reactive protein

The important nuance: The safety advantages of transdermal estradiol over oral Premarin are largely about delivery route (transdermal vs. oral) rather than the estrogen molecule itself. But since transdermal delivery is only readily available with bioidentical estradiol, the practical advantage lies with bioidentical.

Testosterone

For men, there's no meaningful debate — all testosterone products are bioidentical by definition (testosterone is testosterone). The conversation is about delivery method and monitoring, not molecular identity.

For women, bioidentical testosterone is used off-label because no FDA-approved testosterone product exists for women. Compounded testosterone cream is the most common approach. The evidence for testosterone in women (for libido, energy, and well-being) is growing, with the Global Consensus Position Statement on testosterone therapy for women supporting its use for hypoactive sexual desire disorder.

What the Medical Societies Say

The Endocrine Society: Recommends FDA-approved hormone therapy when possible. Acknowledges that compounded hormones have a role when commercial products can't meet clinical needs, but cautions against routine use due to quality concerns.

The North American Menopause Society (NAMS): Supports the use of FDA-approved bioidentical hormones. Raises concerns about compounded products lacking standardized testing. Notes the evidence advantage of micronized progesterone.

ACOG (American College of Obstetricians and Gynecologists): Similar position — FDA-approved bioidentical products are preferred. Compounding should be limited to situations where commercial products are inadequate.

How to Make an Informed Decision

1. Understand that "bioidentical" and "compounded" are not the same thing. You can get bioidentical hormones in FDA-approved, well-regulated products. Choosing bioidentical doesn't require choosing compounded.

1. If you use compounded hormones, choose your pharmacy carefully. PCAB (Pharmacy Compounding Accreditation Board) accredited pharmacies meet higher quality standards. Ask about potency testing and quality assurance.

1. Prefer FDA-approved bioidentical products when available. Prometrium for progesterone, transdermal estradiol patches or gels for estrogen. These give you the bioidentical molecule with manufacturing reliability.

1. Compounding is appropriate when commercial products genuinely don't meet your needs. This includes testosterone for women, specific dose requirements, combination formulations, and ingredient sensitivities.

1. Don't pay a premium for marketing. Some clinics charge significantly more for compounded "custom bioidentical" hormone programs that could be replicated with FDA-approved products at a fraction of the cost.

1. Monitor with lab work regardless of which approach you choose. Hormone levels, liver function, lipids, and cancer screening should be part of any HRT management plan.

Getting Started

At CORAL, Dr. Kim prescribes evidence-based hormone therapy — preferring FDA-approved bioidentical options when they're appropriate and using compounded formulations when clinical need dictates. The goal is effective treatment with appropriate monitoring, not ideology.

If you're considering hormone therapy and want guidance based on evidence rather than marketing, start your evaluation at [coral.clinic/start](https://coral.clinic/start). Dr. Kim will assess your hormonal status, discuss your options, and help you choose an approach that's grounded in research and tailored to your needs.

The best hormone therapy isn't the one with the best branding. It's the one that's right for you.